Skip to main content
. 2018 Apr 24;177(5):489–502. doi: 10.1002/ajmg.b.32637

Table 3.

Coordinates (hg19) of critical regions of 12 SCZ‐associated CNVs

Chr* Start End Location Type Likely candidate gene(s) Criteria for defining this CNV b
chr1 146,527,987 147,394,444 1q21.1 Deletion . Size >50% of critical region
chr1 146,527,987 147,394,444 1q21.1 Duplication . Size >50% of critical region
chr2 50,145,643 51,259,674 2p16.3 Deletion NRXN1 Deletion of at least one exon (NM_004801)
chr3 195,720,167 197,354,826 3q29 Deletion DLG1 Size >50% of critical region
chr7 c 72,744,915 74,142,892 7q11.23 Duplication STX1A Size >50% of critical region
chr15 22,805,313 23,094,530 15q11.2 Deletion CYFIP1 Size >50% of critical region
chr15** c 23,561,268 28,390,339 15q11.2‐q13.1 Duplication UBE3A and GABA receptor gene cluster Full critical region
chr15 31,080,645 32,462,776 15q13.3 Deletion . Size >50% of critical region
chr16 15,511,655 16,293,689 16p13.11 Duplication MYH11 Size >50% of critical region
chr16 21,950,135 22,431,889 16p12.1 Deletion UQCRC2 Size >50% of critical region
chr16 29,650,840 30,200,773 16p11.2 Duplication ALDOA, CORO1A, MAPK3, TAOK2 Size >50% of critical region
chr22 c 19,037,332 21,466,726 22q11.2 Deletion PI4KA, SEPT5 Size >50% of critical region

Chr = chromosome.

aCoordinates taken from Supporting Information of Kendall et al., 2016 (except for **). For analyses, the liftOver tool was used to map from hg19 to hg18 coordinates, specifying minimum ratio of bases that must remap as 0.95.

bSee Supporting Information Table S4 of Kendall et al. (2016).

cCNVs not observed in this study population.